Novel Intranasal Influenza-Vectored Vaccine Corfluvec Provides Protection Against Influenza and COVID-19, Mitigating SARS-CoV-2-Induced Lung Vascular Damage

<b>Introduction</b>: The development of bivalent mucosal vaccines capable of providing protection against both influenza and SARS-CoV-2 is a major public health focus. While most COVID-19 vaccines target the spike (S) protein, the highly conserved nucleocapsid (N) protein represents a strategic targ...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Marina Stukova, Anna-Polina Shurygina, Arman Muzhikyan, Ekaterina Romanovskaya-Romanko, Zhanna Buzitskaya, Marina Shuklina, Anastasia Pulkina, Daria Shamakova, Kirill Kryshen, Mariia Sergeeva, Dmitriy Lioznov
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2026-08-01
סדרה:	Vaccines
נושאים:	SARS-CoV-2 influenza influenza-vectored vaccine nucleocapsid protein mucosal immunization vascular and endothelial integrity
גישה מקוונת:	https://www.mdpi.com/2076-393X/14/8/684
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!